OBI — Ondine Biomedical Share News
0.000.00%
- £41.58m
- £40.21m
- CA$1.20m
RCS - Ondine Biomedical - Ondine appoints Spanish distributer for Steriwave
AnnouncementRCS - Ondine Biomedical - Ondine cuts COVID-19 rate in food processing plant
AnnouncementREG - Ondine Biomedical - PDMR Dealing
AnnouncementRCS - Ondine Biomedical - Ondine CTO receives Lifetime Achievement Award
AnnouncementREG - Ondine Biomedical - PDMR Dealing
AnnouncementRCS - Ondine Biomedical - Ondine presents new efficacy data against MRSA
AnnouncementREG - Ondine Biomedical - Steriwave™ cuts SSI risk by 47% at major hospital
AnnouncementRCS - Ondine Biomedical - Investor Presentation
AnnouncementREG - Ondine Biomedical - Interim results for the six months to 30 June 2022
AnnouncementRCS - Ondine Biomedical - The Ottawa Hospital pilots nasal disinfection
AnnouncementRCS - Ondine Biomedical - New research presented on photodisinfection
AnnouncementREG - Ondine Biomedical - Ondine’s photodisinfection kills ESKAPE pathogens
AnnouncementREG - Ondine Biomedical - Ondine reports successful US Phase 2 trial data
AnnouncementRCS - Ondine Biomedical - Nature reports Ondine therapy suppresses COVID-19
AnnouncementREG - Ondine Biomedical - Ondine appoints RBC and Singer as joint brokers
AnnouncementREG - Ondine Biomedical - Ondine completes US Phase II trial recruitment
AnnouncementREG - Ondine Biomedical - Completion of Nominated Adviser due diligence
AnnouncementREG - Ondine Biomedical - Issue of Equity
AnnouncementREG - Ondine Biomedical - Ondine completes successful SARS-CoV-2 trial
Announcement